Cancer represents the leading global driver of death and is recognized as a critical obstacle
to increasing life expectancy. In recent years, with the development of precision medicine …

With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …

Immunotherapies have been accelerating the development of anti-cancer clinical treatment,
but its low objective responses and severe off-target immune-related adverse events (irAEs) …

Cancer immunotherapy is quickly growing to be the fourth most important cancer therapy,
after surgery, radiation therapy, and chemotherapy. Immunotherapy is the most promising …

Immunotherapy shows a lot of promise for addressing the problems with traditional cancer
treatments. Researchers and clinicians are working to create innovative immunological …

Therapeutic targeting of the immune system, including chimeric antigen receptor-T cell
therapy, immune checkpoint blockade therapy, neoantigen vaccines, and small molecule …

In the past decade, we have witnessed the revolution in cancer therapy, especially in the
rapid development of cancer immunotherapy. In particular, the introduction of nanomedicine …

Metastasis is the leading cause of cancer‐associated death, with poor prognosis even after
extensive treatment. The dormancy of metastatic cancer cells during dissemination or after …

Cancer immunotherapy is an artificial stimulation of the immune system to recognize cancer
cells and activate specific immune cells to target and attack cancer cells. In clinical trials …

Significant advances have been made in the field of cancer immunotherapy by orchestrating
the body's immune system to eradicate cancer cells. However, safety and efficacy concerns …